4.5 Review

Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review

Journal

MECHANISMS OF AGEING AND DEVELOPMENT
Volume 164, Issue -, Pages 113-126

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mad.2017.05.002

Keywords

Oldest-old; Ageing; Neurodegeneration; Cancer incidence; Cancer mortality

Funding

  1. National Institute for Neurological Diseases and Stroke Award (NINDS/NIH) [NS072234]
  2. UCI Cancer Center Award [P30CA062203]
  3. NIH IMSD training grant [R25GM055246]
  4. UCI Provost PhD Fellowship
  5. UCI Diversity Recruitment Fellowship
  6. NIH [R01AG021055]

Ask authors/readers for more resources

Chronic health conditions are commonplace in older populations. The process of aging impacts many of the world's top health concerns. With the average life expectancy continuing to climb, understanding patterns of morbidity in aging populations has become progressively more important. Cancer is an age-related disease, whose risk has been proven to increase with age. Limited information is published about the epidemiology of cancer and the cancer contribution to mortality in the 85 + age group, often referred to as the oldest-old. In this review, we perform a comprehensive assessment of the most recent (2011-2016) literature on cancer prevalence, incidence and mortality in the oldest-old. The data shows cancer prevalence and cancer incidence increases until ages 85-89, after which the rates decrease into 100 + ages. However the number of overall cases has steadily increased over time due to the rise in population. Cancer mortality continues to increase after age 85 +. This review presents an overview of plausible associations between comorbidity, genetics and age-related physiological effects in relation to cancer risk and protection. Many of these age-related processes contribute to the lowered risk of cancer in the oldest-old, likewise other certain health conditions may protect from cancer in this age group.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available